FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

29953411000001109: Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93594101000001110 Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93594201000001115 Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Is a Zafirlukast 20mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has AMP Accolate 20mg tablets (Lexon (UK) Ltd) true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has specific active ingredient Zafirlukast true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start